New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
10:14 EDTTKC, NSH, INDB, TESO, TEVA, NS, BANC, PPC, SIGI, LOWOn The Fly: Analyst Upgrade Summary
Banc of California (BANC) upgraded to Buy from Neutral at Sterne Agee... Independent Bank (INDB) upgraded to Outperform from Market Perform at Keefe Bruyette... Lowe's (LOW) upgraded to Outperform from Perform at Oppenheimer... NuStar Energy (NS) upgraded to Buy from Neutral at Goldman... NuStar GP Holdings (NSH) upgraded to Neutral from Sell at Goldman... Selective Insurance (SIGI) upgraded to Outperform from Market Perform at Keefe Bruyette... Teva (TEVA) upgraded to Neutral from Underweight at JPMorgan... Turkcell (TKC) upgraded to Buy from Neutral at UBS... Pilgrim's Pride (PPC) upgraded to Overweight from Equal Weight at Stephens... Tesco (TESO) upgraded to Overweight from Equalweight at Capital One.
News For BANC;INDB;LOW;NS;NSH;SIGI;TEVA;TKC;PPC;TESO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 11, 2014
07:02 EDTTEVATeva sees FY15 EPS $5.00-$5.30, consensus $5.06
Sees FY15 revenue $19B-$19.4B, consensus $20.07B.
06:09 EDTLOWLowe's CEO sees Return on Invested Capital reaching 19% by 2017
Robert A. Niblock, Lowe's chairman, president and CEO stated, "The housing market and broader economy are recovering just as our transformation is gaining momentum." Robert F. Hull, Jr., Lowe's CFO, commented, "We continue to generate solid cash flow and have exciting opportunities ahead of us. Return on Invested Capital is expected to reach approximately 19% by 2017, an increase of almost 500 basis points over the next three years."
06:05 EDTLOWLowe's sees FY14 EPS about $2.68, consensus $2.67
Subscribe for More Information
December 10, 2014
13:59 EDTTESOT. Rowe Price reports 14.2% passive stake in Tesco
12:06 EDTPPCUSDA lowers 2014 meat production forecast
Subscribe for More Information
10:00 EDTINDB, SIGIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:33 EDTINDBIndependent Bank downgraded to Hold from Buy at Sandler O'Neill
Subscribe for More Information
08:31 EDTTEVATeva announces launch of first generic Celebrex capsules in the U.S.
Teva Pharmaceutical Industries (TEVA) announces the launch of the first FDA-approved generic equivalent to Celebrex Capsules in the United States. Teva is offering 50, 100, 200, and 400 mg strengths of Celecoxib Capsules. Celebrex Capsules, marketed by Pfizer (PFE) had annual sales of approximately $2.56B in the United States, according to IMS data as of October 2014.
08:01 EDTTESOCapital One to hold a conference
Subscribe for More Information
07:38 EDTSIGISelective Insurance downgraded to Market Perform at Keefe Bruyette
Subscribe for More Information
December 9, 2014
10:48 EDTLOWLowe's volatility elevated into analyst and investor meeting
Lowe's December call option implied volatility is at 24, January is at 19, April is at 20; compared to its 26-week average of 21 according to Track Data, suggesting large near term price movement into a company hosted analyst and investor meeting to be held on December 11.
10:23 EDTTKCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:44 EDTTEVAAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
06:40 EDTTKCTurkcell downgraded to Hold from Buy at Deutsche Bank
Subscribe for More Information
December 8, 2014
12:04 EDTLOWLowe's to host analyst and investor meeting
Analyst and Investor Meeting to be held on December 11 at 10 am. Webcast Link
11:30 EDTTEVALeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
08:21 EDTTEVAMerck says looked at all risks, including patent litgation, before Cubist deal
Subscribe for More Information
06:47 EDTTEVAArena says Teva files marketing authorization of Belviq in Israel
Arena Pharmaceuticals (ARNA) disclosed late Friday that Teva Pharmaceutical's (TEVA) local Israeli subsidiary, Abic Marketing Limited, has filed for marketing authorization of Belviq in Israel. In connection with the filing, Arena will receive a milestone payment of $250K.
December 5, 2014
09:32 EDTPPCPilgrim's Pride downgraded to Hold from Buy at BB&T
Subscribe for More Information
07:54 EDTTEVALannett names Michael Bogda as president, effective December 1
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use